Stockreport

Innate Pharma Announces Closing of Global Offering

Innate Pharma S.A. - American Depositary Shares  (IPHA) 
PDF INNATE PHARMA S.A. (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate Pharma” or the “Company”), a French biotechnology company focused on discovering, de [Read more]